David Scott Tomsche net worth and biography

David Tomsche Biography and Net Worth

Director of ImmuCell

Dr. Tomsche was appointed to serve as Chair of the Board of Directors in February 2013 and is a member of the Compensation and Stock Option Committee. He is a large animal veterinarian and owner of Leedstone Inc., an animal health distribution and milking system installation company, J-t Enterprises of Melrose, Inc., an exporter of ImmuCell products, and Dairyridge, Inc., a 2000-head dairy. He served as a director of VetPharm, Inc., an animal health products distributor, from 1995 until the company was sold in 2007. He obtained his Doctor of Veterinary Medicine from the University of Minnesota.

What is David Scott Tomsche's net worth?: The estimated net worth of David Scott Tomsche is at least $523.51 thousand as of November 25th, 2025. Dr. Tomsche owns 52,720 shares of ImmuCell stock worth more than $523,510 as of September 17th. This net worth approximation does not reflect any other investments that Dr. Tomsche may own. Learn More about David Scott Tomsche's net worth.
How do I contact David Scott Tomsche?: The corporate mailing address for Dr. Tomsche and other ImmuCell executives is 56 EVERGREEN DR, PORTLAND ME, 04103. ImmuCell can also be reached via phone at (207) 878-2770 and via email at [email protected]. Learn More on David Scott Tomsche's contact information.
Has David Scott Tomsche been buying or selling shares of ImmuCell?: David Scott Tomsche has not been actively trading shares of ImmuCell over the course of the past ninety days. Most recently, on Tuesday, November 25th, David Scott Tomsche bought 1,633 shares of ImmuCell stock. The stock was acquired at an average cost of $4.76 per share, with a total value of $7,773.08. Following the completion of the transaction, the director now directly owns 52,720 shares of the company's stock, valued at $250,947.20. Learn More on David Scott Tomsche's trading history.
Who are ImmuCell's active insiders?: ImmuCell's insider roster includes Olivier te Boekhorst (President and Chief Executive Officer, Director), and David Tomsche (Director). Learn More on ImmuCell's active insiders.
Are insiders buying or selling shares of ImmuCell?: During the last year, ImmuCell insiders bought shares 2 times. They purchased a total of 9,633 shares worth more than $83,693.08. The most recent insider tranaction occured on June, 18th when CEO Olivier te Boekhorst bought 8,000 shares worth more than $75,920.00. Insiders at ImmuCell own 5.7% of the company. Learn More about insider trades at ImmuCell.
Information on this page was last updated on 6/18/2026.

David Scott Tomsche Insider Trading History at ImmuCell

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/25/2025	Buy	1,633	$4.76	$7,773.08	52,720
2/27/2020	Buy	5,130	$4.98	$25,547.40
8/16/2018	Buy	3,000	$6.67	$20,010.00
3/14/2017	Buy	2,000	$5.43	$10,860.00	71,279
11/7/2016	Buy	4,000	$5.19	$20,760.00
3/21/2016	Buy	955	$6.67	$6,369.85	66,789
9/1/2015	Buy	1,000	$6.73	$6,730.00	59,168
8/28/2015	Buy	1,500	$7.27	$10,905.00	58,168

David Scott Tomsche Buying and Selling Activity at ImmuCell

ImmuCell Company Overview

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, it is developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

Today's Range

Now: $9.97

$9.56

$9.90

50 Day Range

MA: $10.51

$9.58

$11.72

2 Week Range

Now: $9.97

$4.52

$12.10

Volume

32,613 shs

Average Volume

24,720 shs

Market Capitalization

$90.48 million

P/E Ratio

125.14

Dividend Yield

N/A

Beta

0.54